Latest filing published 02 Oct 2026 for Verastem, Inc..
Dan Paterson (chief executive) discloses dealings in Verastem, Inc. to SEC (Form 4). In total, 82 filings cover trades dated from 12 March 2013 to 1 October 2026.
On the open market, the record shows 6 purchases worth €57k and 56 sales worth €1.4M. The net balance comes to €1.3M on the selling side. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 20 share grants. 2026 to date brings no purchases and 4 sales.
Half of the purchases are above €7,169 and half below. Clusters matter here: 3 out of 3 purchases overlapped with buying by a colleague within 30 days. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.
The latest filing, published on 2 October 2026, reports an open-market sale of €311k in Verastem, Inc. The last purchase on record was published on 2 October 2018, which is 2,943 days ago. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 42 declarations